HARROW, INC. — Director's Dealing 2012

May 9, 2012

SEC Form 3/A — Form 3/A

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-01-25

Reporting Person: Schupp Joachim PH (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (Right to Buy)	$0.8	2014-12-14	Common Stock (2464)		Direct
Option (Right to Buy)	$0.72	2016-02-14	Common Stock (375000)		Direct

Footnotes

F1: The stock options, granted on December 15, 2011 with a strike price of $.80 and exercisable immediately upon issuance, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan.

F2: The stock options, granted on February 15, 2012 and effective as of February 28, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Dr. Schupp's options vest over a 3 year period at a strike price of $0.72, with 1/36 of the total number of options vesting each monthly period following the grant date of such options. As of the date of this Form 3 filing, options to purchase 41,668 shares of the Issuer's common stock are exercisable, but no options have been exercised.

F3: This amended Form 3 is being filed by Dr. Schupp to amend his original Form 3 filed on March 27, 2012, for the sole purpose of correcting the exercise price of the stock options granted to Dr. Schupp on February 15, 2012 as described in Footnote 2 above from $0.60 to $0.72.